OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Endocrinology Diabetes and Obesity is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	55
Obesity and infertility: a double whammy	41
Updates in thyroid healthcare delivery: advancing patient-centered care	40
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	35
Advances in assessment and treatment of bone, mineral and parathyroid disorders	34
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	30
Nutrition and thyroid disease	28
Editorial introduction	25
Editorial introduction	25
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	22
Beyond weight loss: tirzepatide as a dual GIP/GLP-1 receptor agonist for obstructive sleep apnea	22
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	22
Recent advances in anaplastic thyroid cancer management	20
Secondary hyperparathyroidism in chronic kidney disease: update on pathophysiology and new treatment targets	19
Financial toxicity in thyroid cancer survivors	16
Interactions between antidiabetes medications and heart–brain axis	15
Editorial introduction	15
The use of anabolic agents in the treatment of osteoporosis: a clinical update	15
Update on fracture risk assessment in osteoporosis	15
An update on bone in diabetes	15
Fibrous dysplasia in children and its management	14
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	14
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	13
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	13
Editorial introductions	12

Epidemiologic changes in thyroid disease	12
Editorial introductions	12
A short history of saturated fat: the making and unmaking of a scientific consensus	12
Precision medicine in diabetes care	12
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	11
Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries	11
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	11
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	11
Type 2 diabetes: a contemporary view from the Asian lens	10
Glucocorticoid withdrawal syndrome: what to expect and how to manage	10
An update on investigation and management of renal bone disease	10
Editorial introductions	10
Assisted reproductive technology outcomes and management considerations for people with epilepsy	10
Editorial introductions	9
Legislation, medicine, and politics: care for gender diverse youth	9
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	9
Novel techniques for assessment of bone tissue material properties	9
Indications for testosterone therapy in men	8
Editorial introductions	8
Multifactorial chylomicronemia syndrome	7
The interaction between gut microbiome and bone health	7
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	7
The future of triglyceride-regulating therapies and registries	7
Microbiome-derived signaling molecules and the brain–gut axis: emerging mechanisms and clinical implications	7
Time to cycle regularity and health risks	7
Revisiting the relationship between weight loss and bone health in people living with obesity: insights from the latest evidence	7